Traumatic brain injury (TBI) is a highly prevalent condition with significant effects on cognition and behavior. While the acute and sub-acute effects of TBI recover over time, relatively little is known about the long-term effects of TBI in relation to neurodegenerative disease. This issue has recently garnered a great deal of attention due to publicity surrounding chronic traumatic encephalopathy (CTE) in professional athletes, although CTE is but one of several neurodegenerative disorders associated with a history of TBI. Here, we review the literative on neurodegenerative disorders linked to remote TBI. We also review the evidence for neuroimaging changes associated with unhealthy brain aging in the context of remote TBI. We conclude that neuroimaging biomarkers have significant potential to increase understanding of the mechanisms of unhealthy brain aging and neurodegeneration following TBI, with potential for identifying those at risk for unhealthy brain aging prior to the clinical manifestation of neurodegenerative disease.
Get full access to this article
View all access options for this article.
References
1.
Alzheimer's Association. (2013). Alzheimer's disease facts and figures. Alzheimer's and Dementia. 9.
2.
FaulM., XuL., WaldM.M., CoronadoV.G. (2010). Traumatic brain injury in the United States: emergency department visits, hospitalizations, and deaths. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control: Atlanta, Georgia.
3.
CoronadoV.G., McGuireL.C., SarmientoK., BellJ., LionbargerM.R., JonesC.D., GellerA.I., KhouryN., and XuL. (2012). Trends in traumatic brain injury in the U.S. and the public health response: 1995–2009. J. Safety Res., 43, 299–307.
4.
CoronadoV.G., McGuireL. C., SarmientoK., BellJ., LionbargerM. R., JonesC. D., GellerA. I., KhouryN., and XuL. (2014). Corrigendum to “Trends in Traumatic Brain Injury in the U.S. and the public health response: 1995–2009” [J. Saf. Res. 43 (2012) 299–307]. J. Safety Res. 48, 117.
5.
McKeeA.C., CantuR.C., NowinskiC.J., Hedley-WhyteE.T., GavettB.E., BudsonA.E., SantiniV.E., LeeH.S., KubilusC.A., and SternR.A. (2009). Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J. Neuropathol. Exp. Neurol., 68, 709–735.
6.
McKeeA.C., GavettB.E., SternR.A., NowinskiC.J., CantuR.C., KowallN.W., PerlD.P., Hedley-WhyteE.T., PriceB., SullivanC., MorinP., LeeH.S., KubilusC.A., DaneshvarD.H., WulffM., and BudsonA.E. (2010). TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J. Neuropathol. Exp. Neurol., 69, 918–929.
7.
McKeeA.C., SteinT.D., NowinskiC.J., SternR.A., DaneshvarD.H., AlvarezV.E., LeeH.S., HallG., WojtowiczS.M., BaughC.M., RileyD.O., KubilusC.A., CormierK.A., JacobsM.A., MartinB.R., AbrahamC.R., IkezuT., ReichardR.R., WolozinB.L., BudsonA.E., GoldsteinL.E., KowallN.W., and CantuR.C. (2013). The spectrum of disease in chronic traumatic encephalopathy. Brain, 136, 43–64.
HazratiL.N., TartagliaM.C., DiamandisP., DavisK.D., GreenR.E., WennbergR., WongJ.C., EzerinsL., and TatorC.H. (2013). Absence of chronic traumatic encephalopathy in retired football players with multiple concussions and neurological symptomatology. Front. Hum. Neurosci., 7, 222.
10.
TartagliaM.C., HazratiL.N., DavisK.D., GreenR.E., WennbergR., MikulisD., EzerinsL.J., KeightleyM., and TatorC. (2014). Chronic traumatic encephalopathy and other neurodegenerative proteinopathies. Front. Hum. Neurosci., 8, 30.
11.
LevineB., KovacevicN., NicaE.I., CheungG., GaoF., SchwartzM.L., and BlackS.E. (2008). The Toronto traumatic brain injury study: injury severity and quantified MRI. Neurology, 70, 771–778.
12.
KrausM.F., SusmarasT., CaughlinB.P., WalkerC.J., SweeneyJ.A., and LittleD.M. (2007). White matter integrity and cognition in chronic traumatic brain injury: a diffusion tensor imaging study. Brain, 130, 2508–2519.
13.
McAllisterT.W., FlashmanL.A., McDonaldB.C., and SaykinA.J. (2006). Mechanisms of working memory dysfunction after mild and moderate TBI: evidence from functional MRI and neurogenetics. J. Neurotrauma, 23, 1450–1467.
14.
SharpD.J., BeckmannC.F., GreenwoodR., KinnunenK.M., BonnelleV., De BoissezonX., PowellJ.H., CounsellS.J., PatelM.C., and LeechR. (2011). Default mode network functional and structural connectivity after traumatic brain injury. Brain, 134, 2233–2247.
15.
LevinH.S., GaryH.E.Jr., EisenbergH.M., RuffR.M., BarthJ.T., KreutzerJ., HighW.M.Jr., PortmanS., FoulkesM.A., JaneJ.A., MarmarouA., and MarshallL.F. (1990). Neurobehavioral outcome 1 year after severe head injury. Experience of the Traumatic Coma Data Bank. J. Neurosurg., 73, 699–709.
FarbotaK.D., SodhiA., BendlinB.B., McLarenD.G., XuG., RowleyH.A., and JohnsonS.C. (2012). Longitudinal volumetric changes following traumatic brain injury: a tensor-based morphometry study. J. Int. Neuropsychol. Soc., 18, 1006–1018.
18.
NgK., MikulisD.J., GlazerJ., KabaniN., TillC., GreenbergG., ThompsonA., LazinskiD., AgidR., ColellaB., and GreenR.E. (2008). Magnetic resonance imaging evidence of progression of subacute brain atrophy in moderate to severe traumatic brain injury. Arch Phys Med Rehabil, 89, 535–544.
19.
GodboltA.K., CancelliereC., HincapieC.A., MarrasC., BoyleE., KristmanV.L., CoronadoV.G., and CassidyJ.D. (2014). Systematic review of the risk of dementia and chronic cognitive impairment after mild traumatic brain injury: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis. Arch. Phys. Med. Rehabil., 95, S245–S256.
20.
SchofieldP.W., TangM., MarderK., BellK., DooneiefG., ChunM., SanoM., SternY., and MayeuxR. (1997). Alzheimer's disease after remote head injury: an incidence study. J. Neurol. Neurosurg. Psychiatry, 62, 11–124.
21.
LehmanE.J., HeinM.J., BaronS.L., and GersicC.M. (2012). Neurodegenerative causes of death among retired National Football League players. Neurology, 79, 1970–1974.
22.
SullivanP., PetittiD. and BarbacciaJ. (1987). Head trauma and age of onset of dementia of the Alzheimer type. JAMA, 257, 2289–2290.
23.
NemetzP.N., LeibsonC., NaessensJ.M., BeardM., KokmenE., AnnegersJ.F., and KurlandL.T. (1999). Traumatic brain injury and time to onset of Alzheimer's disease: a population-based study. Am. J. Epidemiol., 149, 32–40.
24.
JohnsonV.E., StewartW., and SmithD.H. (2012). Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans. Brain Pathol., 22, 142–149.
25.
ChenX.H., JohnsonV.E., UryuK., TrojanowskiJ.Q., and SmithD.H. (2009). A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury. Brain Pathol., 19, 214–223.
26.
PovlishockJ.T. and KatzD.I. (2005). Update of neuropathology and neurological recovery after traumatic brain injury. J. Head Trauma Rehabil., 20, 76–94.
27.
JohnsonV.E., StewartW., and SmithD.H. (2010). Traumatic brain injury and amyloid-beta pathology: a link to Alzheimer's disease?. Nat. Rev. Neurosci., 11, 361–370.
28.
ReitzC., BrayneC., and MayeuxR. (2011). Epidemiology of Alzheimer disease. Nat. Rev. Neurol., 7, 137–152.
29.
MayeuxR., OttmanR., MaestreG., NgaiC., TangM.X., GinsbergH., ChunM., TyckoB., and ShelanskiM. (1995). Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology, 45, 555–557.
30.
GuoZ., CupplesL.A., KurzA., AuerbachS.H., VolicerL., ChuiH., GreenR.C., SadovnickA.D., DuaraR., DeCarliC., JohnsonK., GoR.C., GrowdonJ.H., HainesJ.L., KukullW.A., and FarrerL.A. (2000). Head injury and the risk of AD in the MIRAGE study. Neurology, 54, 1316–1323.
31.
FornoL.S. (1996). Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol., 55, 259–272.
32.
GoldmanS.M., TannerC.M., OakesD., BhudhikanokG.S., GuptaA., and LangstonJ.W. (2006). Head injury and Parkinson's disease risk in twins. Ann. Neurol., 60, 65–72.
33.
MaherN.E., GolbeL.I., LazzariniA.M., MarkM.H., CurrieL.J., WootenG.F., Saint-HilaireM., WilkJ.B., VolcjakJ., MaherJ.E., FeldmanR.G., GuttmanM., LewM., WatersC.H., SchumanS., SuchowerskyO., LafontaineA.L., LabelleN., ViereggeP., PramstallerP.P., KleinC., HubbleJ., ReiderC., GrowdonJ., WattsR., MontgomeryE., BakerK., SingerC., StacyM., and MyersR.H. (2002). Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology, 58, 79–84.
34.
BowerJ.H., MaraganoreD.M., PetersonB.J., McDonnellS.K., AhlskogJ.E., and RoccaW.A. (2003). Head trauma preceding PD: a case-control study. Neurology, 60, 1610–1615.
35.
LiY.J., HauserM.A., ScottW.K., MartinE.R., BoozeM.W., QinX.J., WalterJ.W., NanceM.A., HubbleJ.P., KollerW.C., PahwaR., SternM.B., HinerB.C., JankovicJ., GoetzC.G., SmallG.W., MastagliaF., HainesJ.L., Pericak-VanceM.A., and VanceJ.M. (2004). Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology, 62, 2005–2009.
36.
NearyD., SnowdenJ.S., GustafsonL., PassantU., StussD., BlackS., FreedmanM., KerteszA., RobertP.H., AlbertM., BooneK., MillerB.L., CummingsJ., and BensonD.F. (1998). Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology, 51, 1546–1554.
37.
MackenzieI.R., NeumannM., BigioE.H., CairnsN.J., AlafuzoffI., KrilJ., KovacsG.G., GhettiB., HallidayG., HolmI.E., InceP.G., KamphorstW., ReveszT., RozemullerA.J., Kumar-SinghS., AkiyamaH., BaborieA., SpinaS., DicksonD.W., TrojanowskiJ.Q., and MannD.M. (2010). Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol., 119, 1–4.
38.
KalkondeY.V., JawaidA., QureshiS.U., ShiraniP., WheatonM., Pinto-PatarroyoG.P., and SchulzP.E. (2012). Medical and environmental risk factors associated with frontotemporal dementia: a case-control study in a veteran population. Alzheimers Dement., 8, 204–210.
39.
RossoS.M., LandweerE.J., HoutermanM., Donker KaatL., van DuijnC.M., and van SwietenJ.C. (2003). Medical and environmental risk factors for sporadic frontotemporal dementia: a retrospective case-control study. J. Neurol. Neurosurg. Psychiatry, 74, 1574–1576.
40.
LehmannD.J., SmithA.D., CombrinckM., BarnetsonL., and JoachimC. (2000). Apolipoprotein E epsilon2 may be a risk factor for sporadic frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry., 69, 404–405.
41.
StevensM., van DuijnC.M., de KnijffP., van BroeckhovenC., HeutinkP., OostraB.A., NiermeijerM.F., and van SwietenJ.C. (1997). Apolipoprotein E gene and sporadic frontal lobe dementia. Neurology, 48, 1526–1529.
42.
CompstonA. and ColesA. (2008). Multiple sclerosis. Lancet, 372, 1502–1517.
43.
KangJ.H. and LinH.C. (2012). Increased risk of multiple sclerosis after traumatic brain injury: a nationwide population-based study. J. Neurotrauma, 29, 90–95.
44.
Al-AfasyH.H., Al-ObaidanM.A., Al-AnsariY.A., Al-YatamaS.A., Al-RukaibiM.S., MakkiN.I., SureshA., and AkhtarS. (2013). Risk factors for multiple sclerosis in Kuwait: a population-based case-control study. Neuroepidemiology, 40, 30–35.
45.
PflegerC.C., Koch-HenriksenN., StenagerE., FlachsE.M., and JohansenC. (2009). Head injury is not a risk factor for multiple sclerosis: a prospective cohort study. Mult. Scler., 15, 294–298.
46.
GoldacreM.J., AbisgoldJ.D., YeatesD.G., and SeagroattV. (2006). Risk of multiple sclerosis after head injury: record linkage study. J. Neurol. Neurosurg. Psychiatry, 77, 351–353.
47.
PoserC.M. (1987). Trauma and multiple sclerosis. an hypothesis. J. Neurol., 234, 155–159.
48.
PoserC.M. (1993). The pathogenesis of multiple sclerosis. Additional considerations. J. Neurol. Sci., 115Suppl, S3–S15.
49.
EvangelouN., JacksonM., BeesonD., and PalaceJ. (1999). Association of the APOE epsilon4 allele with disease activity in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry, 67, 203–205.
50.
SchmidtS., BarcellosL.F., DeSombreK., RimmlerJ.B., LincolnR.R., BucherP., SaundersA.M., LaiE., MartinE.R., VanceJ.M., OksenbergJ.R., HauserS.L., Pericak-VanceM.A., and HainesJ.L. (2002). Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis. Am. J. Hum. Genet., 70, 708–717.
51.
ChapmanJ., VinokurovS., AchironA., KarussisD.M., Mitosek-SzewczykK., BirnbaumM., MichaelsonD.M., and KorczynA.D. (2001). APOE genotype is a major predictor of long-term progression of disability in MS. Neurology, 56, 312–316.
52.
FazekasF., Strasser-FuchsS., KolleggerH., BergerT., KristoferitschW., SchmidtH., EnzingerC., SchiefermeierM., SchwarzC., KornekB., ReindlM., HuberK., GrassR., WimmerG., VassK., PfeifferK.H., HartungH.P., and SchmidtR. (2001). Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology, 57, 853–857.
53.
FazekasF., Strasser-FuchsS., SchmidtH., EnzingerC., RopeleS., LechnerA., FloohE., SchmidtR., and HartungH.P. (2000). Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry, 69, 25–28.
54.
WeatherbyS.J., MannC.L., DaviesM.B., CarthyD., FryerA.A., BoggildM.D., YoungC., StrangeR.C., OllierW., and HawkinsC.P. (2000). Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis. Mult. Scler., 6, 32–36.
55.
WeatherbyS.J., MannC.L., FryerA.A., StrangeR.C., HawkinsC.P., StevensonV.L., LearyS.M., and ThompsonA.J. (2000). No association between the APOE epsilon4 allele and outcome and susceptibility in primary progressive multiple sclerosis. J. Neurol. Neurosurg. Psychiatry, 68, 532.
56.
PortaccioE., GorettiB., ZipoliV., NacmiasB., StromilloM.L., BartolozziM.L., SiracusaG., GuidiL., FedericoA., SorbiS., De StefanoN., and AmatoM.P. (2009). APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis. Mult. Scler., 15, 1489–1494.
57.
EisenA. (2009). Amyotrophic lateral sclerosis: a 40-year personal perspective. J. Clin. Neurosci., 16, 505–512.
58.
OkazakiH. (1989). Fundamentals of Neuropathology: Morphologic Basis of Neurologic Disorders, 2nd ed. Igaku-Shoin Medical Publishers, Inc.: New York.
59.
ChioA., BenziG., DossenaM., MutaniR., and MoraG. (2005). Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain, 128, 472–476.
60.
AbelE.L. (2007). Football increases the risk for Lou Gehrig's disease, amyotrophic lateral sclerosis. Percept. Mot. Skills, 104, 1251–1254.
61.
WeisskopfM.G., O'ReillyE.J., McCulloughM.L., CalleE.E., ThunM.J., CudkowiczM., and AscherioA. (2005). Prospective study of military service and mortality from ALS. Neurology, 64, 32–37.
62.
ChenH., RichardM., SandlerD.P., UmbachD.M., and KamelF. (2007). Head injury and amyotrophic lateral sclerosis. Am. J. Epidemiol., 166, 810–816.
63.
SchmidtS., KweeL.C., AllenK.D., and OddoneE.Z. (2010). Association of ALS with head injury, cigarette smoking and APOE genotypes. J. Neurol. Sci., 291, 22–29.
OmaluB.I., DeKoskyS.T., MinsterR.L., KambohM.I., HamiltonR.L., and WechtC.H. (2005). Chronic traumatic encephalopathy in a National Football League player. Neurosurgery, 57, 128–134.
VictoroffJ. (2013). Traumatic encephalopathy: review and provisional research diagnostic criteria. NeuroRehabilitation, 32, 211–224.
68.
OmaluB., BailesJ., HamiltonR.L., KambohM.I., HammersJ., CaseM., and FitzsimmonsR. (2011). Emerging histomorphologic phenotypes of chronic traumatic encephalopathy in American athletes. Neurosurgery, 69, 173–183.
69.
KingA., SweeneyF., BodiI., TroakesC., MaekawaS., and Al-SarrajS. (2010). Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease. Neuropathology, 30, 408–419.
70.
DeKoskyS.T., BlennowK., IkonomovicM.D., and GandyS. (2013). Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers. Nat. Rev. Neurol., 9, 192–200.
71.
NicollJ.A., RobertsG.W., and GrahamD.I. (1995). Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat. Med., 1, 135–137.
72.
HartmanR.E., LaurerH., LonghiL., BalesK.R., PaulS.M., McIntoshT.K., and HoltzmanD.M. (2002). Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease. J. Neurosci., 22, 10083–10087.
73.
SmallG.W., KepeV., SiddarthP., ErcoliL.M., MerrillD.A., DonoghueN., BookheimerS.Y., MartinezJ., OmaluB., BailesJ., and BarrioJ.R. (2013). PET scanning of brain tau in retired national football league players: preliminary findings. Am. J. Geriatr. Psychiatry, 21, 138–144.
74.
AizensteinH.J., NebesR.D., SaxtonJ.A., PriceJ.C., MathisC.A., TsopelasN.D., ZiolkoS.K., JamesJ.A., SnitzB.E., HouckP.R., BiW., CohenA.D., LoprestiB.J., DeKoskyS.T., HalliganE.M., and KlunkW.E. (2008). Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch. Neurol., 65, 1509–1517.
75.
SchottJ.M., BartlettJ.W., FoxN.C., and BarnesJ. (2010). Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Abeta1–42. Ann. Neurol., 68, 825–834.
76.
LevinH.S., GaryH.E.Jr., EisenbergH.M., RuffR.M., BarthJ.T., KreutzerJ., HighW.M.Jr., PortmanS., FoulkesM.A., JaneJ.A., MarmaroueA., and MarshallL.F. (1990). Neurobehavioral outcome 1 year after severe head injury. Experience of the Traumatic Coma Data Bank. J. Neurosurg., 73, 699–709.
77.
LevineB., KovacevicN., NicaE.I., GaoF., SchwartzM.L., and BlackS.E. (2013). Quantified MRI and cognition in TBI with diffuse and focal damage. Neuroimage Clin., 2, 534–541.
78.
StussD.T., ElyP., HugenholtzH., RichardM.T., LaRochelleS., PoirierC.A., and BellI. (1985). Subtle neuropsychological deficits in patients with good recovery after closed head injury. Neurosurgery, 17, 41–47.
79.
StussD.T. and GowC.A. (1992). “Frontal dysfunction” after traumatic brain injury. Neuropsychiatry Neuropsychol. Behav. Neurol., 5, 272–282.
80.
MattsonA.J. and LevinH.S. (1990). Frontal lobe dysfunction following closed head injury. A review of the literature. J. Nerv. Ment. Dis., 178, 282–291.
81.
HimanenL., PortinR., IsoniemiH., HeleniusH., KurkiT., and TenovuoO. (2006). Longitudinal cognitive changes in traumatic brain injury: a 30-year follow-up study. Neurology, 66, 187–192.
82.
HetheringtonC.R., StussD.T., and FinlaysonM.A. (1996). Reaction time and variability 5 and 10 years after traumatic brain injury. Brain Inj., 10, 473–486.
83.
VemuriP., WisteH.J., WeigandS.D., ShawL.M., TrojanowskiJ.Q., WeinerM.W., KnopmanD.S., PetersenR.C., and JackC.R.Jr. (2009). MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology, 73, 294–301.
84.
DickersonB.C., SalatD.H., GreveD.N., ChuaE.F., Rand-GiovannettiE., RentzD.M., BertramL., MullinK., TanziR.E., BlackerD., AlbertM.S., and SperlingR.A. (2005). Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology, 65, 404–411.
85.
KeightleyM.L., SinopoliK.J., DavisK.D., MikulisD.J., WennbergR., TartagliaM.C., ChenJ.K., and TatorC.H. (2014). Is there evidence for neurodegenerative change following traumatic brain injury in children and youth? A scoping review. Front. Hum. Neurosci., 8, 139.
TremblayS., De BeaumontL., HenryL.C., BoulangerY., EvansA.C., BourgouinP., PoirierJ., TheoretH., and LassondeM. (2012). Sports concussions and aging: a neuroimaging investigation. Cereb. Cortex., 23, 1159–1166.
88.
HartJ., KrautM.A., WomackK.B., StrainJ., DidehbaniN., BartzE., ConoverH., MansinghaniS., LuH., and CullumC.M. (2013). Neuroimaging of cognitive dysfunction and depression in aging retired National Football League players: a cross-sectional study. JAMA Neurol., 70, 326–35
89.
McAllisterT.W., SaykinA.J., FlashmanL.A., SparlingM.B., JohnsonS.C., GuerinS.J., MamourianA.C., WeaverJ.B., and YanofskyN. (1999). Brain activation during working memory 1 month after mild traumatic brain injury: a functional MRI study. Neurology, 53, 1300–1308.
90.
ChenJ.K., JohnstonK.M., FreyS., PetridesM., WorsleyK., and PtitoA. (2004). Functional abnormalities in symptomatic concussed athletes: an fMRI study. Neuroimage, 22, 68–82.
91.
JantzenK.J., AndersonB., SteinbergF.L., and KelsoJ.A. (2004). A prospective functional MR imaging study of mild traumatic brain injury in college football players. A.J.N.R. Am. J. Neuroradiol., 25, 738–745.
92.
FordJ.H., GiovanelloK.S., and GuskiewiczK.M. (2013). Episodic memory in former professional football players with a history of concussion: an event-related functional neuroimaging study. J. Neurotrauma, 30, 1683–1701.
93.
HampshireA., MacDonaldA., and OwenA.M. (2013). Hypoconnectivity and hyperfrontality in retired American football players. Sci. Rep., 3, 2972.
94.
TurnerG.R. and LevineB. (2008). Augmented neural activity during executive control processing following diffuse axonal injury. Neurology, 71, 812–818.
95.
DavisS.W., DennisN.A., DaselaarS.M., FleckM.S., and CabezaR. (2008). Que PASA? The posterior-anterior shift in aging. Cereb. Cortex., 18, 1201–1209.
96.
GradyC.L., McIntoshA.R., BeigS., KeightleyM.L., BurianH., and BlackS.E. (2003). Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease. J. Neurosci., 23, 986–993.
97.
TurnerG.R., McIntoshA.R., and LevineB. (2011). Prefrontal compensatory engagement in TBI is due to altered functional engagement of existing networks and not functional reorganization. Front. Syst. Neurosci., 5, 9.
98.
De BeaumontL., TheoretH., MongeonD., MessierJ., LeclercS., TremblayS., EllembergD., and LassondeM. (2009). Brain function decline in healthy retired athletes who sustained their last sports concussion in early adulthood. Brain, 132, 695–708.
99.
LavoieM.E., DupuisF., JohnstonK.M., LeclercS., and LassondeM. (2004). Visual p300 effects beyond symptoms in concussed college athletes. J. Clin. Exp. Neuropsychol., 26, 55–73.
100.
GradyC. (2012). The cognitive neuroscience of ageing. Nat. Rev. Neurosci., 13, 491–505.
101.
HillaryF.G., MedagliaJ.D., GatesK., MolenaarP.C., SlocombJ., PeechatkaA., and GoodD.C. (2011). Examining working memory task acquisition in a disrupted neural network. Brain, 134, 1555–1570.
102.
Reuter-LorenzP.A., and CappellK. A. (2008). Neurocognitive aging and the compensation hypothesis. Current Directions in Psychological Science, 17, 177–182.
103.
McIntoshA.R. and LobaughN.J. (2004). Partial least squares analysis of neuroimaging data: applications and advances. Neuroimage, 23Suppl 1, S250–S263.
104.
BucknerR.L., Andrews-HannaJ.R., and SchacterD.L. (2008). The brain's default network: anatomy, function, and relevance to disease. Ann. N. Y. Acad. Sci., 1124, 1–38.
105.
BonnelleV., LeechR., KinnunenK.M., HamT.E., BeckmannC.F., De BoissezonX., GreenwoodR.J., and SharpD.J. (2011). Default mode network connectivity predicts sustained attention deficits after traumatic brain injury. J. Neurosci., 31, 13442–13451.
106.
SharpD.J., ScottG., and LeechR. (2014). Network dysfunction after traumatic brain injury. Nat. Rev. Neurol., 10, 156–166
107.
SeeleyW.W., CrawfordR.K., ZhouJ., MillerB.L., and GreiciusM.D. (2009). Neurodegenerative diseases target large-scale human brain networks. Neuron., 62, 42–52.
108.
SprengR.N. and TurnerG.R. (2013). Structural covariance of the default network in healthy and pathological aging. J. Neurosci., 33, 15226–15234.
109.
SprengR.N., SepulcreJ., TurnerG.R., StevensW.D., and SchacterD.L. (2013). Intrinsic architecture underlying the relations among the default, dorsal attention, and frontoparietal control networks of the human brain. J. Cogn. Neurosci., 25, 74–86.
110.
BonnelleV., HamT.E., LeechR., KinnunenK.M., MehtaM.A., GreenwoodR.J., and SharpD.J. (2012). Salience network integrity predicts default mode network function after traumatic brain injury. Proc. Natl. Acad. Sci. U. S. A., 109, 4690–4695.
111.
FarbN.A., GradyC.L., StrotherS., Tang-WaiD.F., MasellisM., BlackS., FreedmanM., PollockB.G., CampbellK.L., HasherL., and ChowT.W. (2013). Abnormal network connectivity in frontotemporal dementia: evidence for prefrontal isolation. Cortex, 49, 1856–1873.
112.
St-LaurentM., AbdiH., BurianovaH., and GradyC.L. (2011). Influence of aging on the neural correlates of autobiographical, episodic, and semantic memory retrieval. J. Cogn. Neurosci., 23, 4150–4163.
113.
GradyC. (2012). The cognitive neuroscience of ageing. Nat Rev Neurosci, 13, 491–505.
114.
SperlingR.A., DickersonB.C., PihlajamakiM., VanniniP., LaVioletteP.S., VitoloO.V., HeddenT., BeckerJ.A., RentzD.M., SelkoeD.J., and JohnsonK.A. (2010). Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med., 12, 27–43.
115.
JacksonC.E. and SnyderP.J. (2008). Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer's disease. Alzheimers Dement., 4, S137–S143.
116.
GolobE.J., IrimajiriR., and StarrA. (2007). Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia. Brain, 130, 740–752.
117.
VerlegerR. (2012). Alterations of ERP Components in Neurodegenerative Disease. In: The Oxford Handbook of Event-Related Potential Components.LuckS.J. and KappenmanE.S., (eds). Oxford University Press: New York, NY, pps. 593–610.
118.
PekkonenE. (2000). Mismatch negativity in aging and in Alzheimer's and Parkinson's diseases. Audiol. Neurootol., 5, 216–224.
119.
BabiloniC., LizioR., Del PercioC., MarzanoN., SoricelliA., SalvatoreE., FerriR., CosentinoF.I., TedeschiG., MontellaP., MarinoS., De SalvoS., RodriguezG., NobiliF., VernieriF., UrsiniF., MundiC., RichardsonJ.C., FrisoniG.B., and RossiniP.M. (2013). Cortical sources of resting state EEG rhythms are sensitive to the progression of early stage Alzheimer's disease. J. Alzheimers Dis., 34, 1015–1035.
120.
ElgendiM., VialatteF., CichockiA., LatchoumaneC., JeongJ., and DauwelsJ. (2011). Optimization of EEG frequency bands for improved diagnosis of Alzheimer disease. Conf. Proc. I.E.E.E. Eng. Med. Biol. Soc., 2011, 6087–6091.
121.
MontezT., PoilS.S., JonesB.F., ManshandenI., VerbuntJ.P., van DijkB.W., BrussaardA.B., van OoyenA., StamC.J., ScheltensP., and Linkenkaer-HansenK. (2009). Altered temporal correlations in parietal alpha and prefrontal theta oscillations in early-stage Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A., 106, 1614–1619.
122.
DecoG., JirsaV.K., and McIntoshA.R. (2011). Emerging concepts for the dynamical organization of resting-state activity in the brain. Nat. Rev. Neurosci., 12, 43–56.
123.
CostaM., GoldbergerA.L., and PengC.K. (2002). Multiscale entropy to distinguish physiologic and synthetic RR time series. Comput. Cardiol., 29, 137–140.
124.
Raja BeharelleA., KovacevicN., McIntoshA.R., and LevineB. (2012). Brain signal variability relates to stability of behavior after recovery from diffuse brain injury. Neuroimage, 60, 1528–1537.
125.
AndersonV., CatroppaC., MorseS., HaritouF., and RosenfeldJ. (2005). Functional plasticity or vulnerability after early brain injury?. Pediatrics, 116, 1374–1382.
126.
McCroryP., CollieA., AndersonV., and DavisG. (2004). Can we manage sport related concussion in children the same as in adults?. Br. J. Sports. Med., 38, 516–519.
127.
KatzD.I. and AlexanderM.P. (1994). Traumatic brain injury. Predicting course of recovery and outcome for patients admitted to rehabilitation. Arch. Neurol., 51, 661–670.
128.
BazarianJ.J., BlythB., MookerjeeS., HeH., and McDermottM.P. (2010). Sex differences in outcome after mild traumatic brain injury. J. Neurotrauma, 27, 527–539.
129.
GesselL.M., FieldsS.K., CollinsC.L., DickR.W., and ComstockR.D. (2007). Concussions among United States high school and collegiate athletes. J. Athl. Train., 42, 495–503.
130.
BroshekD.K., KaushikT., FreemanJ.R., ErlangerD., WebbeF., and BarthJ.T. (2005). Sex differences in outcome following sports-related concussion. J. Neurosurg., 102, 856–863.
131.
CovassinT., ElbinR.J., CrutcherB., and BurkhartS. (2013). The management of sport-related concussion: considerations for male and female athletes. Transl. Stroke Res., 4, 420–424.
132.
TierneyR.T., SitlerM.R., SwanikC.B., SwanikK.A., HigginsM., and TorgJ. (2005). Gender differences in head-neck segment dynamic stabilization during head acceleration. Med. Sci. Sports Exerc., 37, 272–279.
133.
TeasdaleG. and JennettB. (1974). Assessment of coma and impaired consciousness. A practical scale. Lancet, 2, 81–84.
134.
AubryM., CantuR., DvorakJ., Graf-BaumannT., JohnstonK., KellyJ., LovellM., McCroryP., MeeuwisseW., and SchamaschP. (2002). Summary and agreement statement of the First International Conference on Concussion in Sport, Vienna 2001. Recommendations for the improvement of safety and health of athletes who may suffer concussive injuries. Br. J. Sports. Med., 36, 6–10.
135.
McCroryP., MeeuwisseW., AubryM., CantuB., DvorakJ., EchemendiaR., EngebretsenL., JohnstonK., KutcherJ., RafteryM., SillsA., BensonB., DavisG., EllenbogenR., GuskiewiczK., HerringS.A., IversonG., JordanB., KissickJ., McCreaM., McIntoshA., MaddocksD., MakdissiM., PurcellL., PutukianM., SchneiderK., TatorC., and TurnerM. (2013). Consensus statement on Concussion in Sport - The 4th International Conference on Concussion in Sport held in Zurich, November 2012. Phys. Ther. Sport., 14, e1–e13.
136.
JordanB.D., RelkinN.R., RavdinL.D., JacobsA.R., BennettA., and GandyS. (1997). Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. JAMA, 278, 136–140.
137.
LipskyR.H., SparlingM.B., RyanL.M., XuK., SalazarA.M., GoldmanD., and WardenD.L. (2005). Association of COMT Val158Met genotype with executive functioning following traumatic brain injury. J. Neuropsychiatry. Clin. Neurosci., 17, 465–471.
138.
KruegerF., PardiniM., HueyE.D., RaymontV., SolomonJ., LipskyR.H., HodgkinsonC.A., GoldmanD., and GrafmanJ. (2011). The role of the Met66 brain-derived neurotrophic factor allele in the recovery of executive functioning after combat-related traumatic brain injury. J. Neurosci., 31, 598–606.
